Back to search

Virginia Commonwealth University

SELECTIVE NON-PEPTIDE MU-OPIOID RECEPTOR ANTAGONIST: DESIGN, SYNTHESIS AND BIOLOGICAL STUDIES

Abstract

dc:description.abstract

There are currently many opioid agonists available for clinical use as analgesics. However, many of these opioid agonists have notorious side effects including respiratory depression and may lead to addiction and dependence. Problems associated with these opioid agonists are determined to come from their interactions with the mu-opioid receptor. Opioid antagonists, such as naltrexone, have shown to aid in the treatment of opioid addiction. Although naltrexone has high affinity to the mu-opioid receptor, it lacks selectivity. Novel selective mu-opioid receptor antagonists were designed based on the identification of important pharmacophore elements in several known mu-opioid receptor agonists and antagonists. These compounds were synthesized and in vitro biological assays were conducted to determine their affinity to all three opioid receptors. Also, molecular modeling studines were conducted to help visualize the interactions between the mu-opioid receptor and these ligands. Finally, four lead compounds have been identified for further optimization.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Medicinal Chemistry

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Aschenbach, Lindsey
Contributors dc:contributor
  • Yan Zhang

Subjects

dc:subject × 4

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Aschenbach, Lindsey. SELECTIVE NON-PEPTIDE MU-OPIOID RECEPTOR ANTAGONIST: DESIGN, SYNTHESIS AND BIOLOGICAL STUDIES. Thesis thesis, https://doi.org/10.25772/ZBRA-DW79